-
2023
- 11LepiMag™ Cell-free DNA Extraction notified
- 11Scale-Up Tips fund approved
- 10Entrepreneurial Growth Technology Development Business Support Program approved
- 10Clinical Test GMP certified
- 05Regulatory Support Platform Establishment Project for Bioinnovation project approved
-
2022
- 12Series B Fund ($5.3M)
- 10Singapore MethyLiverDx Tech. transfer & Project Kick-off
- 09International Liver Cancer Association (ILCA), Results presentation
- 07AACC Conference (USA), Preliminary clinical results presentation
- 07Customized Technical Support Program for IVD Medical Devices project approved
- 05KHIDI fund approved
- 04medical device technology commercialization fund approved
- 03BIG3 start-up fund approved
- 03MethyLiverPro Analytical validation from KTC
- 03Collaboration agreement with DxD for LDT development
-
2021
- 12Auristone x DxDhub MethyLiverDx NDA
- 12MOU with Auristone for product commercialization
- 12IVD medical device manufacturing license
- 08MethyLiverDx pilot test started
- 07Office and lab expansion
- 07Clinical Test GMP submitted
-
2020
- 06TIPS startup business fund granted
- 04Production facility established
- 04Corporate R&D center established
- 03Relocation of company (Seoul-Forest A Tower)
-
2019
- 12Series A Fund ($3.8M)
- 11Technology transfer contract with Yonsei R&DB foundation
- 11Ministry of SMEs and Startup grant approved
- 10Venture company certified
- 07Corporation established
